A PCR-based protocol for the generation of a recombinant West Nile virus

Virus Research

Volumn 144, Issue 1-2, 2009, Pages 35-43

  Maeda, Akihiko ^a   Murata, Ryo ^a   Akiyama, Minoru ^a   Takashima, Ikuo ^a   Kariwa, Hiroaki ^a   Watanabe, Tomomasa ^b   Kurane, Ichiro ^c   Maeda, Junko ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Recombinant virus; West Nile virus

Indexed keywords

COMPLEMENTARY DNA; VIRUS RNA;

ANIMAL CELL; ARTICLE; CELL STRAIN BHK; CELL STRAIN HEK293; CONTROLLED STUDY; DNA SYNTHESIS; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MAMMAL CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERO CELL; VIRUS GENOME; VIRUS RECOMBINANT; WEST NILE FLAVIVIRUS;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; DNA, COMPLEMENTARY; DNA, VIRAL; HUMANS; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC; TRANSFECTION; VIROLOGY; WEST NILE VIRUS;

MAMMALIA; WEST NILE VIRUS;

EID: 69249230857     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2009.03.021     Document Type: Article

References (47)

1. Arjona A., Ledizet M., Anthony K., Bonafe N., Modis Y., Town T., and Fikrig E. West Nile virus envelope protein inhibits dsRNA-induced innate immune responses. J. Immunol. 179 12 (2007) 8403-8409
2. Baric R.S., and Sims A.C. Development of mouse hepatitis virus and SARS-CoV infectious cDNA constructs. Curr. Top. Microbiol. Immunol. 287 (2005) 229-252
3. Beasley D.W., Davis C.T., Whiteman M., Granwehr B., Kinney R.M., and Barrett A.D. Molecular determinants of virulence of West Nile virus in North America. Arch. Virol. Suppl. 18 (2004) 35-41
4. Beasley D.W., Whiteman M.C., Zhang S., Huang C.Y., Schneider B.S., Smith D.R., Gromowski G.D., Higgs S., Kinney R.M., and Barrett A.D. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J. Virol. 79 13 (2005) 8339-8347
5. Bondre V.P., Jadi R.S., Mishra A.C., Yergolkar P.N., and Arankalle V.A. West Nile virus isolates from India: evidence for a distinct genetic lineage. J. Gen. Virol. 88 Pt 3 (2007) 875-884
6. Bredenbeek P.J., Kooi E.A., Lindenbach B., Huijkman N., Rice C.M., and Spaan W.J. A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication. J. Gen. Virol. 84 Pt 5 (2003) 1261-1268
7. Brinton M.A. The molecular biology of West Nile virus: a new invader of the western hemisphere. Annu. Rev. Microbiol. 56 (2002) 371-402
8. Campbell M.S., and Pletnev A.G. Infectious cDNA clones of Langat tick-borne flavivirus that differ from their parent in peripheral neurovirulence. Virology 269 1 (2000) 225-237
9. Dauphin G., Zientara S., Zeller H., and Murgue B. West Nile: worldwide current situation in animals and humans. Comp. Immunol. Microbiol. Infect. Dis. 27 5 (2004) 343-355
10. Deardorff E., Estrada-Franco J., Brault A.C., Navarro-Lopez R., Campomanes-Cortes A., Paz-Ramirez P., Solis-Hernandez M., Ramey W.N., Davis C.T., Beasley D.W., Tesh R.B., Barrett A.D., and Weaver S.C. Introductions of West Nile virus strains to Mexico. Emerg. Infect. Dis. 12 2 (2006) 314-318
11. Finke S., and Conzelmann K.K. Recombinant rhabdoviruses: vectors for vaccine development and gene therapy. Curr. Top. Microbiol. Immunol. 292 (2005) 165-200
12. Forns X., Bukh J., Purcell R.H., and Emerson S.U. How Escherichia coli can bias the results of molecular cloning: preferential selection of defective genomes of hepatitis C virus during the cloning procedure. Proc. Natl. Acad. Sci. U.S.A. 94 25 (1997) 13909-13914
13. Gritsun T.S., and Gould E.A. Infectious transcripts of tick-borne encephalitis virus, generated in days by RT-PCR. Virology 214 2 (1995) 611-618
14. Hall R.A., Nisbet D.J., Pham K.B., Pyke A.T., Smith G.A., and Khromykh A.A. DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus. Proc. Natl. Acad. Sci. U.S.A. 100 18 (2003) 10460-10464
15. Hanna S.L., Pierson T.C., Sanchez M.D., Ahmed A.A., Murtadha M.M., and Doms R.W. N-linked glycosylation of West Nile virus envelope proteins influences particle assembly and infectivity. J. Virol. 79 21 (2005) 13262-13274
16. He B., Paterson R.G., Ward C.D., and Lamb R.A. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology 237 2 (1997) 249-260
17. Kapoor M., Zhang L., Mohan P.M., and Padmanabhan R. Synthesis and characterization of an infectious dengue virus type-2 RNA genome (New Guinea C strain). Gene 162 2 (1995) 175-180
18. Kedarnath N., Prasad S.R., Dandawate C.N., Koshy A.A., George S., and Ghosh S.N. Isolation of Japanese encephalitis & West Nile viruses from peripheral blood of encephalitis patients. Indian J. Med. Res. 79 (1984) 1-7
19. Khromykh A.A., and Westaway E.G. Completion of Kunjin virus RNA sequence and recovery of an infectious RNA transcribed from stably cloned full-length cDNA. J. Virol. 68 7 (1994) 4580-4588
20. Komar N., and Clark G.G. West Nile virus activity in Latin America and the Caribbean. Rev. Panam Salud Publica 19 2 (2006) 112-117
21. Lai C.J., Zhao B.T., Hori H., and Bray M. Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc. Natl. Acad. Sci. U.S.A. 88 12 (1991) 5139-5143
22. Lanciotti R.S., Roehrig J.T., Deubel V., Smith J., Parker M., Steele K., Crise B., Volpe K.E., Crabtree M.B., Scherret J.H., Hall R.A., MacKenzie J.S., Cropp C.B., Panigrahy B., Ostlund E., Schmitt B., Malkinson M., Banet C., Weissman J., Komar N., Savage H.M., Stone W., McNamara T., and Gubler D.J. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286 5448 (1999) 2333-2337
23. Maeda J., Takagi H., Hashimoto S., Kurane I., and Maeda A. A PCR-based protocol for generating West Nile virus replicons. J. Virol. Methods 148 1-2 (2008) 244-252
24. Martina B.E., Koraka P., van den Doel P., Rimmelzwaan G.F., Haagmans B.L., and Osterhaus A.D. DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha. Virus Res. 135 1 (2008) 64-71
25. McElroy K.L., Tsetsarkin K.A., Vanlandingham D.L., and Higgs S. Characterization of an infectious clone of the wild-type yellow fever virus Asibi strain that is able to infect and disseminate in mosquitoes. J. Gen. Virol. 86 Pt 6 (2005) 1747-1751
26. Montigny C., Penin F., Lethias C., and Falson P. Overcoming the toxicity of membrane peptide expression in bacteria by upstream insertion of Asp-Pro sequence. Biochim. Biophys. Acta 1660 1-2 (2004) 53-65
27. Neumann G., and Kawaoka Y. Reverse genetics systems for the generation of segmented negative-sense RNA viruses entirely from cloned cDNA. Curr. Top. Microbiol. Immunol. 283 (2004) 43-60
28. Nielsen H.S., Liu G., Nielsen J., Oleksiewicz M.B., Botner A., Storgaard T., and Faaberg K.S. Generation of an infectious clone of VR-2332, a highly virulent North American-type isolate of porcine reproductive and respiratory syndrome virus. J. Virol. 77 6 (2003) 3702-3711
29. Racaniello V.R. Studying poliovirus with infectious cloned cDNA. Rev. Infect. Dis. 6 Suppl. 2 (1984) S514-S515
30. Ramanathan M.P., Chambers J.A., Pankhong P., Chattergoon M., Attatippaholkun W., Dang K., Shah N., and Weiner D.B. Host cell killing by the West Nile Virus NS2B-NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway. Virology 345 1 (2006) 56-72
31. Rice C.M., Grakoui A., Galler R., and Chambers T.J. Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol. 1 3 (1989) 285-296
32. Scherret J.H., Mackenzie J.S., Khromykh A.A., and Hall R.A. Biological significance of glycosylation of the envelope protein of Kunjin virus. Ann. N. Y. Acad. Sci. 951 (2001) 361-363
33. Shi P.Y., Tilgner M., and Lo M.K. Construction and characterization of subgenomic replicons of New York strain of West Nile virus. Virology 296 2 (2002) 219-233
34. Shirato K., Miyoshi H., Goto A., Ako Y., Ueki T., Kariwa H., and Takashima I. Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus. J. Gen. Virol. 85 Pt 12 (2004) 3637-3645
35. Smithburn K.C., Hughes T.P., Burke A.W., and Paul J.H. A neurotropic virus isolated from the blood of a native of Uganda. Am. J. Trop. Med. 20 (1940) 471-492
36. Stephenson I., Nicholson K.G., Wood J.M., Zambon M.C., and Katz J.M. Confronting the avian influenza threat: vaccine development for a potential pandemic. Lancet Infect. Dis. 4 8 (2004) 499-509
37. Sumiyoshi H., Hoke C.H., and Trent D.W. Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates. J. Virol. 66 9 (1992) 5425-5431
38. Takimoto T., Hurwitz J.L., Zhan X., Krishnamurthy S., Prouser C., Brown B., Coleclough C., Boyd K., Scroggs R.A., Portner A., and Slobod K.S. Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus. Viral Immunol. 18 2 (2005) 255-266
39. Ternovoi V.A., Protopopova E.V., Surmach S.G., Gazetdinov M.V., Zolotykh S.I., Shestopalov A.M., Pavlenko E.V., Leonova G.N., and Loktev V.B. The genotyping of the West Nile virus in birds in the far eastern region of Russia in 2002-2004. Mol. Gen. Mikrobiol. Virusol. 4 (2006) 30-35
40. Theriault S., Groseth A., Artsob H., and Feldmann H. The role of reverse genetics systems in determining filovirus pathogenicity. Arch. Virol. Suppl. 19 (2005) 157-177
41. Ulper L., Sarand I., Rausalu K., and Merits A. Construction, properties, and potential application of infectious plasmids containing Semliki Forest virus full-length cDNA with an inserted intron. J. Virol. Methods 148 1-2 (2008) 265-270
42. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 7 (2005) 791-796
43. Witko S.E., Kotash C.S., Nowak R.M., Johnson J.E., Boutilier L.A., Melville K.J., Heron S.G., Clarke D.K., Abramovitz A.S., Hendry R.M., Sidhu M.S., Udem S.A., and Parks C.L. An efficient helper-virus-free method for rescue of recombinant paramyxoviruses and rhadoviruses from a cell line suitable for vaccine development. J. Virol. Methods 135 1 (2006) 91-101
44. Wu X., and Rupprecht C.E. Glycoprotein gene relocation in rabies virus. Virus Res. 131 1 (2008) 95-99
45. Yamshchikov V., Mishin V., and Cominelli F. A new strategy in design of +RNA virus infectious clones enabling their stable propagation in E. coli. Virology 281 2 (2001) 272-280
46. Young M.J., Kelly L., Larkin P.J., Waterhouse P.M., and Gerlach W.L. Infectious in vitro transcripts from a cloned cDNA of barley yellow dwarf virus. Virology 180 1 (1991) 372-379
47. Zhang F., Huang Q., Ma W., Jiang S., Fan Y., and Zhang H. Amplification and cloning of the full-length genome of Japanese encephalitis virus by a novel long RT-PCR protocol in a cosmid vector. J. Virol. Methods 96 2 (2001) 171-182